FinnCap restated their corporate rating on shares of Proteome Sciences plc (LON:PRM) in a research note issued to investors on Tuesday.

Proteome Sciences plc (LON PRM) opened at GBX 3.62 ($0.05) on Tuesday. Proteome Sciences plc has a 12 month low of GBX 2.61 ($0.03) and a 12 month high of GBX 6 ($0.08).

In other news, insider Martin Diggle bought 256,520 shares of the firm’s stock in a transaction that occurred on Wednesday, October 18th. The shares were purchased at an average price of GBX 3 ($0.04) per share, with a total value of £7,695.60 ($10,121.79). In the last three months, insiders have purchased 505,616 shares of company stock worth $1,516,848.

TRADEMARK VIOLATION WARNING: “FinnCap Reiterates Corporate Rating for Proteome Sciences plc (PRM)” was published by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark legislation. The legal version of this report can be accessed at https://www.watchlistnews.com/finncap-reiterates-corporate-rating-for-proteome-sciences-plc-prm/1724975.html.

Proteome Sciences plc Company Profile

Proteome Sciences plc is a protein biomarker company specializing in proteomics and peptidomics services and applications, and mass spectrometry (MS) protein analysis. The Company is engaged in biomarker research and development in applied proteomics and workflows using its techniques to detect and characterize differentially expressed proteins in diseases for diagnostic, prognostic and therapeutic applications.

Receive News & Ratings for Proteome Sciences plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences plc and related companies with Analyst Ratings Network's FREE daily email newsletter.